MarketBeat·Oct 26, 2026
5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-CapsThe S&P 500 recently sat just 2.5% below its all-time high. Look past the index, though, and the picture gets uglier.
DuPont's retained portfolio appears to be stabilizing after a roughly 45% revenue reset, with gross margin recovering from about 31% in 2025Q4 to 35.7% in 2026Q3 and operating margin rising from 11.1% in 2026Q1 to 14.8%, which suggests a more favorable specialty mix.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue has reset to roughly $1.7B to $1.9B per quarter, with gross margin improving to 35.7% and operating margin reaching 14.8% in 2026Q3, though net margin of 6.6% and declining net income from $161M to $123M suggest the earnings base has not yet proven durable.
DuPont provides leading engineered products and solutions across healthcare, water, and industrial segments, driving innovation and market leadership.
The company's robust financial health and competitive advantages position it well for long-term growth and stability.
Successful cost-saving measures and operational efficiencies are expected to improve margins and support upside potential.
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 3, 2026 | $2.09+11.8% vs $1.87 | $1.9B+1.4% vs $1.8B |
Q3 2026 Aug 4, 2026 | $1.88+6.8% vs $1.76 | $1.8B+0.7% vs $1.8B |
Q2 2026 May 5, 2026 | $1.65+238.0% vs $0.49 | $1.7B+0.9% vs $1.7B |
Q1 2026 Feb 10, 2026 | $1.38+7.0% vs $1.29 | $1.7B+0.3% vs $1.7B |
The S&P 500 recently sat just 2.5% below its all-time high. Look past the index, though, and the picture gets uglier.
Financial Management Professionals Inc. grew its position in DuPont de Nemours, Inc. (NYSE: DD) by 9,323.0% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,973 shares of the basic materials company's stock after buying an additional 6,899
DD expands its bioprocessing portfolio with AmberChrom SIL silica gel, targeting high-purity peptide purification amid growing demand for GLP-1 therapeutics.
New silica-based chromatography media helps biopharmaceutical manufacturers achieve demanding purity targets while supporting integrated purification workflows from crude purification through final polishing WILMINGTON, Del., Oct. 22, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced the launch of DuPont™ AmberChrom™ SIL silica gel, a new reverse phase silica-based solution designed to support the purification and manufacture of peptide therapeutics, including glucagon-like peptide-1 ( GLP-1 ) receptor agonists.
Benchmark DD against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for DuPont de Nemours, Inc. (DD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $146.52 | $19.78B | 65.76 | -44.7% | 4.26% | 2.15% | 2.92% | |
| $31.40 | $22.68B | -28.23 | -6.97% | -1.9% | -4.16% | 6.67% | |
| $60.72 | $19.6B | 15.06 | -25.18% | 4.07% | 12.31% | 9.02% | |
| $64.41 | $7.37B | 11.48 | -6.71% | 7.15% | 10.51% | 5.12% | |
| $46.49 | $5.1B | 19.55 | -7.16% | 2.66% | 5.76% | 0.26% | |
| $9.45 | $1.66B | -9.91 | -5.85% | -2.68% | -5.64% | 8.95% |
DuPont de Nemours, Inc. (DD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
DuPont de Nemours, Inc. (DD) SEC filings — annual & quarterly reports (10-K, 10-Q)
Nov 3, 2026·SEC
Aug 4, 2026·SEC
Jun 24, 2026·SEC
Get notified when DD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
DuPont de Nemours, Inc. (DD) stock FAQ — growth, dividends, profitability & financials explained
DuPont de Nemours, Inc. (DD) reported $7.06B in revenue over the trailing twelve months. Revenue was $6.85B in fiscal year 2025. That is 66% less than the $20.05B of fiscal year 1996.
DuPont de Nemours, Inc. (DD) revenue fell by 43.5% over the trailing twelve months, compared with the twelve months before.
Yes. DuPont de Nemours, Inc. (DD) earned $301.0M in net income over the trailing twelve months (a 4.3% net margin).
Yes. DuPont de Nemours, Inc. (DD) pays a dividend that yields 2.92% at the current price, a moderate yield.
DuPont de Nemours, Inc. (DD) had a return on equity (ROE) of 2.2% over the trailing twelve months. That is below the market's typical 10-15%.
DuPont de Nemours, Inc. (DD) generated $883.0M in free cash flow over the trailing twelve months.
